Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Clinical Genitourinary Cancer
|
February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
Daniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.
JCO Precision Oncology
|
September 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer
Jacob E Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
Molecular Cancer Research : MCR
|
January 27, 2022
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications
Xin Dong, Hui Xue, Fan Mo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
Jamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.
JCO Oncology Practice
|
September 21, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial
Huma Q Rana, Jill E Stopfer, Michelle Weitz, et al.
Nature Medicine
|
March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancer
Meng Xiao He, Michael S Cuoco, Jett Crowdis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Clinical Genitourinary Cancer
|
February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
Daniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.
JCO Precision Oncology
|
September 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer
Jacob E Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
Molecular Cancer Research : MCR
|
January 27, 2022
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications
Xin Dong, Hui Xue, Fan Mo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
Jamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.
JCO Oncology Practice
|
September 21, 2023
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial
Huma Q Rana, Jill E Stopfer, Michelle Weitz, et al.
Nature Medicine
|
March 5, 2021
Transcriptional mediators of treatment resistance in lethal prostate cancer
Meng Xiao He, Michael S Cuoco, Jett Crowdis, et al.
Page
of 2